Bayer, Novartis settle Betaseron battle
DrugResearcher.com - London,UK
... the launch of the treatment coinciding with regulatory submission of the company's hotly anticipated once-daily oral MS therapy, FTY720 (fingolimod). ...
See all stories on this topic

Novartis in $200 mn deal with Bayer Schering
PharmaBiz Mon, 17 Sep 2007 3:42 AM PDT
Novartis has completed an agreement with Bayer Schering Pharma AG (Bayer Schering) related to various rights for the multiple sclerosis treatment Betaseron (interferon beta-1b) and has received a one-time payment of approximately US$ 200 million.

Too many drugs still withheld
Daily Post - Llandudno Junction,UK
And it was made worse by the fact that the only drug that could help her, Tysabri, was not available to her because of Welsh NHS funding constraints. ...
See all stories on this topic

Bayer completes acquisition of US biologics manufacturing facility
WebWire (press release) - Atlanta,GA,USA
Bayer Schering Pharma AG, Germany, has completed the acquisition of a biologics manufacturing facility in Emeryville, California from Novartis. ...
See all stories on this topic

Pipex Pharmaceuticals Receives State of Michigan Economic ...
CNNMoney.com - USA
Pipex Pharmaceuticals, Inc. ("Pipex") is a specialty pharmaceutical company that is developing proprietary, late-stage drug candidates for the treatment of ...
See all stories on this topic